Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
Combined company begins trading on the Nasdaq Stock Market at a pro forma enterprise value of approximately $288 million, marking the arrival of a new pure-play regenerative medicine and longevity platform on the U.S. public markets Combined company begins trading on the Nasdaq Stock Market at a pro forma enterprise value of approximately $288 million, marking the arrival of a new pure-play regenerative medicine and longevity platform on the U.S. public markets
Combined company begins trading on the Nasdaq Stock Market at a pro forma enterprise value of approximately $288 million, marking the arrival of a new pure-play regenerative medicine and longevity platform on the U.S. public markets Combined company begins trading on the Nasdaq Stock Market at a pro forma enterprise value of approximately $288 million, marking the arrival of a new pure-play regenerative medicine and longevity platform on the U.S. public markets
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.